13.07.2015 Views

rologie i - European Congress of Virology

rologie i - European Congress of Virology

rologie i - European Congress of Virology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

5 th <strong>European</strong> <strong>Congress</strong> <strong>of</strong> <strong>Virology</strong>26. VIRAL INFECTIONS INTRANSPLANT ANDIMMUNOCOMPROMISED PATIENTSPosters: REF 539 to REF 562REF 539Determination <strong>of</strong> anti HCMV T Cell response <strong>of</strong> potential recipientsand donors in cellular immunotherapy <strong>of</strong> leukemic patients aftertransplantation <strong>of</strong> hematopoetic stem cells (SCT)Sarka NEMECKOVA 1 , Katarina BABIAROVA 1 , Jitka KRYSTOFOVA 1 ,Petr HAINZ 1 , Kamila ZURKOVA 1 , Marketa STASTNA MARKOVA 21 Institute <strong>of</strong> Hematology and Blood Transfusion, Department <strong>of</strong> experimentalvirology, Prague, CZECH REPUBLIC; 2 Institute <strong>of</strong> Hematologyand Blood Transfusion, Transplantation Ward, Prague, CZECH REPU-BLICCytomegalovirus (CMV) reactivation in immunosuppressed patients isassociated with morbidity and mortality. The testing CMV specific T cellresponse can help to find the patients which are in a high risk <strong>of</strong> CMVdisease. Such patients would pr<strong>of</strong>it from adoptive transfer <strong>of</strong> CMV specificT cells. Cellular immune response against CMV <strong>of</strong> 14 patients after allogeneicSCT was monitored for 180 days by ELISPOT interferon gammawith the aim to find patients with insufficient control <strong>of</strong> CMV reactivation.The second aim was to compare various forms <strong>of</strong> CMV antigen forin vitro stimulation. The patients after SCT were classified according tothe anti CMV T cell response, the presence <strong>of</strong> CMV DNA in the blood andthe response <strong>of</strong> T cells after stimulation with anti CD3 antibody into fourgroups: 1) CMV DNA (neg.), anti CMV T cells + (pos.); 2) CMV DNA,anti CMV T cells; 3) CMV DNA +, anti CMV T cells, CD3+; 4) CMVDNA +, anti HCMV T cells, CD3. Patients <strong>of</strong> groups 3,4 would benefitfrom adoptive transfer. By testing the recall response <strong>of</strong> T cells <strong>of</strong> donorsagainst pp65, IE 1, US3, UL36, US29, UL55 peptide pools, pp65, IE 1epitopes or CMV lysate we found that inclusion <strong>of</strong> US3, UL36, US29,UL55 as testing antigens can increase significantly the overall response<strong>of</strong> anti CMV T cells. We observed that stimulation with the long 30merpeptides from pp65 or IE 1 sequence induced activation <strong>of</strong> CD8 and CD4antiviral T cells. The long peptides could be used for T cell activation<strong>of</strong> multiple epitopes if the MHCI binding minimal CTL epitopes are notknown.Supported by NT/13898/2012 grant.donor/recipient status (D R). Virus load (VL) was measured by RochePCR. In all 10 D+R patients primary HCMV infection led to a development<strong>of</strong> total and IgG3 HCMV ABs, but 2 patients showed no IgG1 response.Total HCMV IgG, and IgG3 AB RLUs remained stable post TX within 1log during follow up in all 9DR+andD+R+ patients without detectableVL and in 86% and 96% <strong>of</strong> 28 patients with detectable VL, respectively.In contrast, IgG1 subclass ABs were variable in 46% <strong>of</strong> the patients (RLUvariation >1log) who developed HCMV VL. In 7 cases IgG1 declinedprior to viremia and in 6 patients IgG1 increased during virus replication.HCMV total IgG and IgG3 AB responses are stable over time, while IgG1ABs exhibit substantial variability in relation to virus replication. Theclinical implications <strong>of</strong> these data will be further elucidated.REF 541Detection <strong>of</strong> TS polyomavirus from tonsillar tissues <strong>of</strong> children andadultsMohammadreza SADEGHI 1 , Lea HEDMAN 1,2 , Leena MaijaAALTONEN 3 , Maria SÖDERLUND VENERMO 1 , Klaus HEDMAN 1,21 Department <strong>of</strong> <strong>Virology</strong>, Haartman Institute, University <strong>of</strong> Helsinki, Helsinki,FINLAND; 2 Department <strong>of</strong> <strong>Virology</strong> and Immunology, HelsinkiUniversity Central Hospital Laboratory Division, Helsinki, FINLAND;3 Department <strong>of</strong> Otorhinolaryngology Head and Neck Surgery, HelsinkiUniversity Central Hospital, Helsinki, FINLANDBackground: in the past few years several new polyomaviruses <strong>of</strong> humanshave been discovered. Trichodysplasia spinulosa associated polyomavirus(TSPyV) was identified in a patient with trichodysplasia spinulosa (TS), arare follicular skin disease <strong>of</strong> immunocompromised patients. Seroepidemiologicalstudies indicate that TSPyV is ubiquitous and infects ∼ 70% <strong>of</strong>healthy individuals. We have shown that the tonsil may be a site <strong>of</strong> WUPyVinitial infection and <strong>of</strong> MCPyV persistence. Whether TSPyV persistenceoccurs in the lymphoid system is unknown.Methods: to determine whether tonsils harbor TSPyV, we tested a total <strong>of</strong>229 matched pairs <strong>of</strong> tonsillar tissues and sera from asymptomatic childrenor adults (overall mean age 21.0 years). The samples were also screenedfor the single copy human RNase P gene by real time quantitative PCR(qPCR). TSPyV was detected by qPCRs with Taq Man probes and primerpairs targeting the VP1 or LT genes. Results: TSPyV DNA was detectedin 8 <strong>of</strong> 229 (3.5%) tonsillar tissues, from both cohorts, and in none <strong>of</strong>the corresponding sera. Sequence analysis <strong>of</strong> the 8 virus positive samplesconfirmed the identity <strong>of</strong> TSPyV.Conclusions: these data provide the first evidence <strong>of</strong> TSPyV in tonsillartissue and suggest that (i) tonsils may serve as an initial site <strong>of</strong> TS polyomavirusinfection and that (ii) lymphoid tissue may be a persistence sitefor this virus.REF 540Human Cytomegalovirus specific IgG subclass antibody kinetics inthe follow up after lung transplantationBenedikt SIMON, Irene GÖRZER, Elisabeth PUCHHAMMERSTÖCKLDepartment <strong>of</strong> <strong>Virology</strong>, Med Uni Wien, Vienna, AUSTRIAHuman cytomegalovirus (HCMV) may cause severe infections in lungtransplant recipients (LTRs). HCMV specific AB response limits virusreplication, but the kinetics <strong>of</strong> subclass AB response after transplantation(TX) are not clear.We analyzed the HCMV specific IgG AB kinetics <strong>of</strong> total IgG and <strong>of</strong> thedominant IgG AB subclasses 1 and 3 after TX and assessed whether theseare associated with HCMV replication in the follow up. HCMV AB titers <strong>of</strong>53 LTRs were measured repeatedly post TX using the MEDAC CMV IgGELISA, modified for subclass 1 and 3 ABs. ODs were expressed in relativelight units (RLUs). Cut <strong>of</strong>fs were established in patients with HCMVREF 542The Reactivation <strong>of</strong> Immunomodulating Beta Herpesviruses Infectionin Patients Undergoing Microvascular Free Flap SurgeriesArnis VILKS 1,2 , Romans DZALBS 4 , Santa RASA 3 , Zaiga NoraKRUKLE 3 , Viesturs BOKA 1 , Biruta MAMAJA 2,1 , ModraMUROVSKA 31 Riga Eastern Clinical University Hospital Gailezers, Riga, LATVIA;2 Riga Stradins University, Department <strong>of</strong> Anaesthesiology and Reanimatology,Riga, LATVIA; 3 Riga Stradins University, A. Kirchenstein Institute<strong>of</strong> Microbiology and <strong>Virology</strong>, Riga, LATVIA; 4 Riga Stradins University,Faculty <strong>of</strong> Medicine, Riga, LATVIABeta herpesviruses HHV 6 and HHV 7 are immunomodulating viruses.They have the ability to impair host defence system seriously and maycontribute to other infectious pathogens due to immune suppression. Wehave investigated the effect <strong>of</strong> long lasting microvascular free flap surgeryS270 Vi<strong>rologie</strong>, Vol 17, supplément 2, septembre 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!